This shows that the relationship between gene mutation and response or nonresponse to treatment may not be significant, which should be further studied ( 160 ).
← all excerpts
Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019.
1
—
—